Catalog Number PY2101NCM |
Device Problem
Failure to Deliver (2338)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 06/14/2022 |
Event Type
malfunction
|
Manufacturer Narrative
|
Oem manufacture: the manufacturing location for this product is cair.This site is an oem manufacturing site.Therefore, bd corporate headquarters in (b)(4) has been listed in sections manufacturer name, city and state and manufacturer site and the (b)(4) fda registration number has been used for the manufacture report number.Date of event: unknown.The date received by manufacturer has been used for this field.Medical device lot #: an invalid lot # of 22a03-tc was provided by the initial reporter.Device expiration date: unknown.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.Device manufacture date: unknown.
|
|
Event Description
|
It was reported that the bd neutraclear¿ 2-way extension set was clogged.The following information was provided by the initial reporter: when giving bolus medication, the line appears to be blocked.However, the line does spray through but the orange rubber blocks.It does not "spring back".So the line could be blocked because the medication is no longer being delivered.Now this was only nacl, but with cardiotics it is a big problem.
|
|
Event Description
|
It was reported that the bd neutraclear¿ 2-way extension set was clogged.The following information was provided by the initial reporter: when giving bolus medication, the line appears to be blocked.However, the line does spray through but the orange rubber blocks.It does not "spring back".So the line could be blocked because the medication is no longer being delivered.Now this was only nacl, but with cardiotics it is a big problem.
|
|
Manufacturer Narrative
|
The following fields were updated due to additional information: d10: device available for eval? yes.D10: returned to manufacturer on: 15-sep-2022.H6: investigation summary: two py2101ncm samples from lot 22a03-tc were received without packaging for investigation; residual fluid was visible in the devices.The samples were received alongside a glass pre-filled syringe of metoclopramide.A visual inspection of the returned samples confirmed the customer's experience, as the pistons of the neutraclears of each sample were noted to be recessed.The details of this feedback were shared with the legal manufacturer of the product, cair lgl for investigation.Their analysis confirmed that three of the four neutraclear components had a recessed piston; a closer inspection of the components identified that the internal needle of the neutraclears had been damaged.Furthermore they analysed the male luer of the returned syringe, which confirmed that it was incompatible for use with the neutraclear® valve; in this instance it is likely that the internal needle of the neutraclear was damaged during connection with returned syringe, resulting in the piston remaining recessed upon disconnection.A review of the production records for lot 22a03-tc did not identify any in-process testing issues or quality deviations which may have resulted in a report of this nature.
|
|
Search Alerts/Recalls
|